MOPA — Medical Oncology Prior Authorization - Local Development build (v0.1.1-snapshot-080926) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: MOPA Local Code System

Raw xml | Download

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="ocpa-codes"/>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ocpa-codes</b></p><a name="ocpa-codes"> </a><a name="hcocpa-codes"> </a><p>This case-sensitive code system <code>http://hl7.org/fhir/us/codex-mopa/CodeSystem/ocpa-codes</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">anti-cancer<a name="ocpa-codes-anti-cancer"> </a></td><td>Anti-Cancer Component</td><td>A regimen component that is an anti-cancer therapeutic agent (e.g., cytotoxic, targeted, immunotherapy).</td></tr><tr><td style="white-space:nowrap">supportive<a name="ocpa-codes-supportive"> </a></td><td>Supportive Care Component</td><td>A regimen component that is supportive (e.g., antiemetic, growth factor, steroid not used as anti-cancer therapy).</td></tr><tr><td style="white-space:nowrap">premedication<a name="ocpa-codes-premedication"> </a></td><td>Premedication Component</td><td>A regimen component administered as premedication prior to the primary agent.</td></tr></table></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="cic"/>
  </extension>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="informative">
      <extension
                 url="http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom">
        <valueCanonical
                        value="http://hl7.org/fhir/us/codex-mopa/ImplementationGuide/hl7.fhir.us.codex-mopa"/>
      </extension>
    </valueCode>
  </extension>
  <url value="http://hl7.org/fhir/us/codex-mopa/CodeSystem/ocpa-codes"/>
  <version value="0.1.1-snapshot-080926"/>
  <name value="OcpaCodesCS"/>
  <title value="MOPA Local Code System"/>
  <status value="draft"/>
  <experimental value="true"/>
  <date value="2026-09-08T18:17:28-04:00"/>
  <publisher value="HL7 International / Clinical Interoperability Council"/>
  <contact>
    <name value="HL7 International / Clinical Interoperability Council"/>
    <telecom>
      <system value="url"/>
      <value value="http://www.hl7.org/Special/committees/cic"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="ciclist@lists.HL7.org"/>
    </telecom>
  </contact>
  <description
               value="Local codes defined by the MOPA IG for concepts that do not yet have
an established representation in LOINC, SNOMED CT, or mCODE. These codes are migration
candidates and should be retired in favor of standard codes as they become available."/>
  <jurisdiction>
    <coding>
      <system value="urn:iso:std:iso:3166"/>
      <code value="US"/>
      <display value="United States of America"/>
    </coding>
  </jurisdiction>
  <purpose
           value="mCODE Migration Candidate — individual codes submitted to LOINC and SNOMED CT.
This code system will be retired once standard codes are assigned. It is NOT intended to
be a permanent artifact of this IG. See the mCODE Gap Proposals page for the full proposal backlog."/>
  <caseSensitive value="true"/>
  <content value="complete"/>
  <count value="3"/>
  <concept>
    <code value="anti-cancer"/>
    <display value="Anti-Cancer Component"/>
    <definition
                value="A regimen component that is an anti-cancer therapeutic agent (e.g., cytotoxic, targeted, immunotherapy)."/>
  </concept>
  <concept>
    <code value="supportive"/>
    <display value="Supportive Care Component"/>
    <definition
                value="A regimen component that is supportive (e.g., antiemetic, growth factor, steroid not used as anti-cancer therapy)."/>
  </concept>
  <concept>
    <code value="premedication"/>
    <display value="Premedication Component"/>
    <definition
                value="A regimen component administered as premedication prior to the primary agent."/>
  </concept>
</CodeSystem>